Speed Post News Network
New Delhi : The Competition Commission of India (CCI) has approved the proposal of Tau Investment to acquire shares in J B Chemicals. The proposed combination envisages acquisition of up to 64.90% of share capital of J B Chemicals & Pharmaceuticals Limited by Tau Investment Holdings Pte. Ltd. (Tau Investment).
Tau Investment is a company incorporated in Singapore. It is an indirect wholly owned subsidiary of KKR Asian Fund III LP. It is an affiliate of funds, vehicles and/or entities managed and/or advised by Kohlberg Kravis Roberts & Co. LP., which is an indirect subsidiary of KKR & Co. Inc.
J B Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company, headquartered in Mumbai, Maharashtra, according to a PIB release. It is listed on BSE Limited and the National Stock Exchange of India Limited.